Skip to content

A clinical study on Amavata wsrt Rheumatoid Arthritis.

â??A Clinical Comparative Evaluation of Chitrakadi Churna With Vaitarana Basti and Devdarvyadi Churna With Vaitarana Basti Specifically on Disability Index Score of Amavata wsrt Rheumatoid Arthritisâ??

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014679
Enrollment
60
Registered
2018-06-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- With controlled Systemic disorder

Interventions

Intervention1: Chitrakadi Churna(Chitrakmula Haritki Kutki Ativisha Indrayava Patha) 5gms BD Vaitaran Basti 180 ml after meal. contents-Amlika 20gm Guda 10gm Saindhava 5gm Tiltaila 10ml Gomutra 80ml :

Sponsors

Government Ayurved college Nagpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients having signs and symptoms of Amavata mentioned in Ayurvedic texts. 2) All patients fulfilling a score of 6/10 is needed for classification of a patient as having definite Rheumatoid Arthritis which is American criteria of rheumatoid arthritis (2010). 3) Patients of either sex aged between 30-60 years. 4) Patient willing and able to participate in the study. 5) Patients who have not participated in any research projects since last 6 months. 6) Patients of rheumatoid arthritis having controlled hypertension and diabetes mellitus may also be included. 7) Patients of Aamvata having Sama Avastha will only be included in study.

Exclusion criteria

Exclusion criteria: 1) Patients who are not willing for trial. 2) Patients having gross disability in performing daily normal routine i.e. bed ridden patients or confined to a wheelchair or have to take help to perform daily routine activity. 3) Patients having gouty arthritis, syphilitic arthritis, psoriatic arthritis, rheumatic arthritis, tubercular arthritis, gonococcal arthritis etc. 4) Patients with poorly controlled Hypertension (B.P. > 160/100mmHg). 5) Patients with poorly controlled Diabetes Mellitus (HBA1C 6.5 to 10mmol/dl) 6) Patients with the evidence of malignancy. 7) Patients on prolonged medication ( >6weeks) with corticosteroids, or any other drugs that may have an influence on the outcome of the study. 8) Patients who are currently participating in any other clinical trials (since last 6 months). 9) Any other conditions which the researcher thinks may jeopardize the study. 10) Pregnant or lactating ladies 11)Patient with chronicity more than >3 years. 12) Patient with contracture and having deformity in the joints. 13) Patients of Aamvata having Niraam- Avastha.

Design outcomes

Primary

MeasureTime frame
1. Tocompare the effect of oral administration of Chitrakadi Churna along with Vaitarana Basti with that of Devdarvyadi Churna along with Vaitarana Basti on clinical features of Amavata and disability index score of rheumatoid arthritis.Timepoint: 1.0 Day assessment (Before treatment) on admission day 2.Langhana for 3-5 days 3.One Vaitarana Basti 15 days in morning and oral administration of Chitrakadi / Devdarvyadi churna for two times per day with lukewarm water. Dose is 5 gms twice a day.

Secondary

MeasureTime frame
To study the literature of Amavata and Rheumatoid arthritisTimepoint: one and haif year

Countries

India

Contacts

Public ContactShaktijitr M Babar

Department of Kayachikitsa,Government Ayurved college,Nagpur

kabraprakash2711@gmail.com9225226567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026